Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ogo, CN"'
Publikováno v:
ecancermedicalscience
Prostate cancer (PCa) has become the most prevalent cancer among males in Nigeria, and similar to other black populations, Nigerian men present with more advanced disease at an earlier age than in several other ethnic groups. In this unscreened, high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd825813932236a357b1a04684fdd1d0
http://europepmc.org/articles/PMC4154944
http://europepmc.org/articles/PMC4154944
Autor:
White JA; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Genetics, Morehouse School of Medicine, Atlanta, Georgia, USA., Kaninjing ET; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; School of Health and Human Performance, Georgia College & State University, Milledgeville, Georgia, USA., Adeniji KA; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria., Jibrin P; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, National Hospital Abuja, Abuja, Federal Capital Territory, Nigeria., Obafunwa JO; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Ogo CN; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Surgery, Federal Medical Centre, Abeokuta, Ogun State, Nigeria., Mohammed F; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Ahmadu Bello University, Zaria, Kaduna State, Nigeria., Popoola A; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; College of Health Sciences, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria., Fatiregun OA; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Clinical Oncology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oluwole OP; College of Health Sciences, University of Abuja, Abuja, Federal Capital Territory, Nigeria., Thorpe RJ Jr; Center for Health Disparities Solutions, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Karanam B; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria., Elhussin I; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Urology, Johns Hopkins University School of Medicine, Brady Urological Institute, Baltimore, Maryland, USA., Ambs S; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Tang W; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Davis M; Department of Genetics, Morehouse School of Medicine, Atlanta, Georgia, USA.; Department of Surgery, New York Presbyterian-Weill Cornell Medicine, New York, New York, USA., Polak P; Quest Diagnostics, Secaucus, New Jersey, USA., Campbell MJ; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Brignole KR; Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA., Rotimi SO; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Biochemistry and Covenant Applied Informatics and Communication Africa Centre of Excellence, Covenant University, Ota, Nigeria., Dean-Colomb W; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Piedmont Medical Oncology-Newnan, Newnan, Georgia, USA., Odedina FT; Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, Florida, USA., Yates C; Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.; Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Urology, Johns Hopkins University School of Medicine, Brady Urological Institute, Baltimore, Maryland, USA.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publikováno v:
The Prostate [Prostate] 2024 Apr; Vol. 84 (5), pp. 460-472. Date of Electronic Publication: 2024 Jan 08.
Autor:
White JA; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Kaninjing ET; Georgia College & State University, Milledgeville, Georgia., Adeniji KA; University of Ilorin Teaching Hospital, Nigeria, Ilorin., Jibrin P; National Hospital Abuja, Nigeria, Abuja., Obafunwa JO; Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Ogo CN; Federal Medical Centre, Abeokuta, Nigeria., Mohammed F; Ahmadu Bello University, Zaria Nigeria., Popoola A; University of Ilorin Teaching Hospital, Nigeria, Ilorin., Fatiregun OA; Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oluwole OP; University of Abuja, FCT, Nigeria., Karanam B; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Elhussin I; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama., Ambs S; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, Bethesda, Maryland., Tang W; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, NCI, Bethesda, Maryland., Davis M; Department of Surgery, New York Presbyterian - Weill Cornell Medicine, New York, New York., Polak P; C2i Genomics, New York, New York., Campbell MJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Brignole KR; University of North Carolina Chapel Hill, North Carolina., Rotimi SO; Department of Biochemistry, Covenant University, Ota, Nigeria., Dean-Colomb W; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama.; Piedmont Medical Oncology - Newnan, Newnan, Georgia., Odedina FT; Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, Florida., Martin DN; Division of Cancer Control and Population Sciences, NCI, Rockville, Maryland., Yates C; Tuskegee University, Center for Cancer Research, Tuskegee, Alabama.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Sep 16; Vol. 2 (9), pp. 1005-1016. Date of Electronic Publication: 2022 Sep 16 (Print Publication: 2022).
Autor:
Ezenwankwo EF; Division of Physiological Sciences, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.; African Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.; Cancer Research Initiative, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa., Nnate DA; Department of Nursing and Community Health, School of Health and Life Sciences, Glasgow Caledonian University, UK., Oladoyinbo CA; African Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.; Department of Nutrition and Dietetics, Federal University of Agriculture, Abeokuta, Nigeria., Dogo HM; African Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.; Department of Surgery, Urology Division, University of Maiduguri, Maiduguri, Nigeria., Idowu AA; African Behavioral Research (ABeR) Center, Federal University of Agriculture, Abeokuta, Nigeria.; Department of Chemical Pathology, Ekiti State University College of Medicine, Ado-Ekiti, Nigeria., Onyeso CP; Military Hospital, GRA, Port Harcourt, Rivers State, Nigeria., Ogo CN; Department of Surgery, Federal Medical Centre Abeokuta, NG.; African Behavioral Research (ABeR) Center, Federal Univeristy of Agriculture, Abeokuta, Nigeria., Ogunsanya M; College of Pharmacy, University of Oklahoma Health Sciences Center, 1110 N. Stonewall Ave, Oklahoma City, US., Bamidele O; Institute for Clinical and Applied Health Research, Hull York Medical School, R341, University of Hull, UK., Nnaji CA; Cancer Research Initiative, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.; Cochrane South Africa, South African Medical Research Council, Francie Van Zijl Drive, Parow Valley, Cape Town 7501, South Africa.
Publikováno v:
Annals of global health [Ann Glob Health] 2022 May 10; Vol. 88 (1), pp. 29. Date of Electronic Publication: 2022 May 10 (Print Publication: 2022).
Autor:
Ezenwankwo EF; Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Oladoyimbo CA; Department of Nutrition and Dietetics, Federal University of Agriculture, Abeokuta, Nigeria., Dogo HM; Department of Surgery, Urology Division, University of Maiduguri, Maiduguri, Nigeria., Idowu AA; Department of Chemical Pathology, Ekiti State University College of Medicine, Ado-Ekiti, Nigeria., Alabi AO; Department of Radiotherapy and Oncology, Lagos University Teaching Hospital, Idi-araba, Lagos, Nigeria., Oyelekan A; Department of Surgery, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria., Ajayi AO; Department of Surgery, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria., Ogo CN; Department of Surgery, Federal Medical Centre Abeokuta, Abeokuta, Nigeria., Mbadiwe O; Department of Surgery, College of Medicine, University of Nigeria, Enugu, Nigeria., Nwadilibe IB; Department of Medical Rehabilitation, College of Medicine, University of Nigeria, Enugu, Nigeria., Rivers B; Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, USA., Kaninjing E; School of Health and Human Performance, Georgia College and State University, Milledgeville, GA, USA.
Publikováno v:
Cancer investigation [Cancer Invest] 2021 Jul-Aug; Vol. 39 (6-7), pp. 529-538. Date of Electronic Publication: 2021 Jun 01.
Publikováno v:
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria [Niger J Med] 2015 Apr-Jun; Vol. 24 (2), pp. 131-6.
Autor:
Obalum DC; Department of Surgery State House Medical Centre Aso Rock, Abuja., Eyesan SU, Fiberesima F, Ogo CN, Nzewi C, Mijinyawa M
Publikováno v:
The Nigerian postgraduate medical journal [Niger Postgrad Med J] 2013 Sep; Vol. 20 (3), pp. 223-7.
Autor:
Tijani KH; Department of Surgery, Section of Urology, Lagos University Teaching Hospital, Lagos, Nigeria., Ogo CN; Department of Surgery, Section of Urology, Federal Medical Centre, Abeokuta, Nigeria., Ojewola RW; Department of Surgery, Section of Urology, Lagos University Teaching Hospital, Lagos, Nigeria., Akanmu NO; Department of Anaesthesia, Lagos University Teaching Hospital, Lagos, Nigeria.
Publikováno v:
Arab journal of urology [Arab J Urol] 2012 Dec; Vol. 10 (4), pp. 440-4. Date of Electronic Publication: 2012 Aug 15.
Autor:
Obalum DC; Department of Surgery State House Medical Centre, Aso Rock, Abuja Nigeria. Obalum1@yahoo.com, Fiberesima F, Eyesan SU, Ogo CN, Nzew C, Mijinyawa M
Publikováno v:
The Nigerian postgraduate medical journal [Niger Postgrad Med J] 2012 Sep; Vol. 19 (3), pp. 175-80.
Autor:
Akinremi TO; Department of Pathology, Federal Medical Centre, Abeokuta, Nigeria. bakinremi2@aol.com., Ogo CN, Olutunde AO
Publikováno v:
Infectious agents and cancer [Infect Agent Cancer] 2011 Sep 23; Vol. 6 Suppl 2, pp. S8. Date of Electronic Publication: 2011 Sep 23.